Technology

Eyegate Pharmaceuticals

$6.68
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.35 (+5.53%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell EYEG and other stocks, options, and ETFs commission-free!

About EYEG

Eyegate Pharmaceuticals, Inc. Common Stock, also called Eyegate Pharmaceuticals, is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes EGP-437 and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA. The listed name for EYEG is Eyegate Pharmaceuticals, Inc. Common Stock.

CEO
Stephen From
Employees
10
Headquarters
Waltham, Massachusetts
Founded
1998
Market Cap
41.85M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
188.04K
High Today
$6.78
Low Today
$6.26
Open Price
$6.28
Volume
86.28K
52 Week High
$8.18
52 Week Low
$3.20

Collections

EYEG Earnings

-$1.15
-$0.77
-$0.38
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 4, After Hours

You May Also Like

HBCP
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure